EW FY 2024 Earnings — Edwards Lifesciences Corporation Revenue & Financial Results | Market Cap Arena

EWEdwards Lifesciences Corporation

$50B

FY 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$5.4B+8.6% YoY

Gross Profit

$4.3B79.5% margin

Operating Income

$1.4B25.3% margin

Net Income

$4.2B76.7% margin

EPS (Diluted)

$6.97

Cash Flow

Operating Cash Flow

$542M

Free Cash Flow

$290M

Stock-Based Comp.

$162M

Balance Sheet

Total Assets

$13.1B

Total Liabilities

$3.0B

Stockholders' Equity

$10.0B

Cash & Equivalents

$3.0B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5.4B	$5.0B	+8.6%
Gross Profit	$4.3B	$4.0B	+8.8%
Operating Income	$1.4B	$1.4B	-3.4%
Net Income	$4.2B	$1.4B	+197.7%